Guardant Health, Inc.
NASDAQ:GH
28.61 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -479.449 | -654.588 | -384.77 | -246.283 | -67.851 | -84.263 | -83.221 | -46.139 |
| Depreciation & Amortization
| 42.881 | 35.962 | 22.271 | 16.065 | 13.609 | 7.136 | 5.206 | 3.693 |
| Deferred Income Tax
| -86.619 | 0 | 12.896 | 11.167 | -1.597 | -0.769 | 6.414 | 0.287 |
| Stock Based Compensation
| 90.759 | 94.685 | 151.449 | 144.113 | 16.954 | 6.851 | 3.67 | 1.971 |
| Change In Working Capital
| 53.84 | 61.564 | -40.468 | -47.665 | -6.092 | -1.127 | -4.989 | 2.454 |
| Accounts Receivables
| 8.378 | 0.375 | -44.353 | -5.463 | -7.389 | -22.903 | -9.292 | -2.786 |
| Inventory
| -10.35 | -20.926 | -7.957 | -7.535 | -6.045 | -1.849 | -4.518 | -0.351 |
| Accounts Payables
| 88.591 | 60.328 | 8.638 | -7.859 | 4.341 | 5.046 | 1.25 | 2.145 |
| Other Working Capital
| -32.779 | 21.787 | 3.204 | -26.808 | 3.001 | 18.579 | 7.571 | 3.446 |
| Other Non Cash Items
| 53.613 | 152.914 | 29.605 | 18.676 | -2.157 | -0.013 | 0.685 | 1.024 |
| Operating Cash Flow
| -324.975 | -309.463 | -209.017 | -103.927 | -47.134 | -72.185 | -72.235 | -36.71 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -20.486 | -77.461 | -75.035 | -54.059 | -21.285 | -20.203 | -8.983 | -1.766 |
| Acquisitions Net
| 0 | -227.277 | -11.88 | 17.886 | -7.328 | 41 | 2.302 | 0 |
| Purchases Of Investments
| -635.495 | -327.723 | -940.23 | -1,125.575 | -614.29 | -287.45 | -236.835 | -341.415 |
| Sales Maturities Of Investments
| 1,494.7 | 555 | 952.11 | 562.548 | 325.333 | 154.625 | 75.402 | 369.383 |
| Other Investing Activites
| 1.531 | 227.277 | 11.88 | -17.886 | -0.068 | -132.825 | -2.302 | 27.968 |
| Investing Cash Flow
| 840.25 | 149.816 | -63.155 | -617.086 | -317.57 | -153.028 | -170.416 | 26.202 |
| Financing Activities: | ||||||||
| Debt Repayment
| 0 | -0.071 | -0.93 | -0.174 | -0.127 | -0.443 | -26.088 | -0.379 |
| Common Stock Issued
| 482.544 | 11.941 | 17.865 | 355.73 | 367.743 | 254.006 | 0.765 | 40.315 |
| Common Stock Repurchased
| -11.197 | -7.878 | -83.759 | 7.095 | 0 | -0.172 | -12.557 | -0.1 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | -3.156 | 0 | 0 |
| Other Financing Activities
| -5.169 | -200.963 | -83.759 | 1,054.751 | 367.431 | 42.926 | 319.536 | 40.319 |
| Financing Cash Flow
| 477.375 | -189.093 | -66.824 | 1,410.307 | 367.304 | 293.161 | 281.656 | 39.84 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| -0.911 | -1.6 | -1.693 | 0.455 | 0.084 | 0 | 0 | 0 |
| Net Change In Cash
| 991.89 | -842.628 | -340.689 | 689.749 | 2.684 | 67.948 | 39.005 | 29.332 |
| Cash At End Of Period
| 1,133.537 | -350.34 | 492.288 | 832.977 | 143.228 | 140.544 | 72.596 | 33.591 |